Seroprevalence of SARS-CoV-2 among frontline health care personnel in a multistate hospital network - 13 Academic Medical Centers, April-June 2020

Wesley H. Self; Mark W. Tenforde; William B. Stubblefield; Leora R. Feldstein; Jay S. Steingrub; Nathan I. Shapiro; Adit A. Ginde; Matthew E. Prekker; Samuel M. Brown; Ithan D. Peltan; Michelle N. Gong; Michael S. Aboodi; Akram Khan; Matthew C. Exline; D. Clark Files; Kevin W. Gibbs; Christopher J. Lindsell; Todd W. Rice; Ian D. Jones; Natasha Halasa; H. Keipp Talbot; Carlos G. Grijalva; Jonathan D. Casey; David N. Hager; Nida Qadir; Daniel J. Henning; Melissa M. Coughlin; Jarad Schiffer; Vera Semenova; Han Li; Natalie J. Thornburg; Manish M. Patel

doi:10.15585/mmwr.mm6935e2

Seroprevalence of SARS-CoV-2 among frontline health care personnel in a multistate hospital network - 13 Academic Medical Centers, April-June 2020

Wesley H. Self, Mark W. Tenforde, William B. Stubblefield, Leora R. Feldstein, Jay S. Steingrub, Nathan I. Shapiro, Adit A. Ginde, Matthew E. Prekker, Samuel M. Brown, Ithan D. Peltan, Michelle N. Gong, Michael S. Aboodi, Akram Khan, Matthew C. Exline, D. Clark Files, Kevin W. Gibbs, Christopher J. Lindsell, Todd W. Rice, Ian D. Jones, Natasha HalasaH. Keipp Talbot, Carlos G. Grijalva, Jonathan D. Casey, David N. Hager, Nida Qadir, Daniel J. Henning, Melissa M. Coughlin, Jarad Schiffer, Vera Semenova, Han Li, Natalie J. Thornburg, Manish M. Patel

Pulmonary and Critical Care Medicine

Research output: Contribution to journal › Article › peer-review

147 Scopus citations

Original language	English (US)
Pages (from-to)	1221-1226
Number of pages	6
Journal	Morbidity and Mortality Weekly Report
Volume	69
Issue number	35
DOIs	https://doi.org/10.15585/mmwr.mm6935e2
State	Published - Sep 4 2020

ASJC Scopus subject areas

Epidemiology
Health(social science)
Health Information Management
Health, Toxicology and Mutagenesis

Access to Document

10.15585/mmwr.mm6935e2

Cite this

Self, W. H., Tenforde, M. W., Stubblefield, W. B., Feldstein, L. R., Steingrub, J. S., Shapiro, N. I., Ginde, A. A., Prekker, M. E., Brown, S. M., Peltan, I. D., Gong, M. N., Aboodi, M. S., Khan, A., Exline, M. C., Files, D. C., Gibbs, K. W., Lindsell, C. J., Rice, T. W., Jones, I. D., ... Patel, M. M. (2020). Seroprevalence of SARS-CoV-2 among frontline health care personnel in a multistate hospital network - 13 Academic Medical Centers, April-June 2020. Morbidity and Mortality Weekly Report, 69(35), 1221-1226. https://doi.org/10.15585/mmwr.mm6935e2

Seroprevalence of SARS-CoV-2 among frontline health care personnel in a multistate hospital network - 13 Academic Medical Centers, April-June 2020. / Self, Wesley H.; Tenforde, Mark W.; Stubblefield, William B. et al.
In: Morbidity and Mortality Weekly Report, Vol. 69, No. 35, 04.09.2020, p. 1221-1226.

Research output: Contribution to journal › Article › peer-review

Self, WH, Tenforde, MW, Stubblefield, WB, Feldstein, LR, Steingrub, JS, Shapiro, NI, Ginde, AA, Prekker, ME, Brown, SM, Peltan, ID, Gong, MN, Aboodi, MS, Khan, A, Exline, MC, Files, DC, Gibbs, KW, Lindsell, CJ, Rice, TW, Jones, ID, Halasa, N, Talbot, HK, Grijalva, CG, Casey, JD, Hager, DN, Qadir, N, Henning, DJ, Coughlin, MM, Schiffer, J, Semenova, V, Li, H, Thornburg, NJ & Patel, MM 2020, 'Seroprevalence of SARS-CoV-2 among frontline health care personnel in a multistate hospital network - 13 Academic Medical Centers, April-June 2020', Morbidity and Mortality Weekly Report, vol. 69, no. 35, pp. 1221-1226. https://doi.org/10.15585/mmwr.mm6935e2

@article{f70a0179a8b9406c85c8cbd166c1ba53,

title = "Seroprevalence of SARS-CoV-2 among frontline health care personnel in a multistate hospital network - 13 Academic Medical Centers, April-June 2020",

author = "Self, {Wesley H.} and Tenforde, {Mark W.} and Stubblefield, {William B.} and Feldstein, {Leora R.} and Steingrub, {Jay S.} and Shapiro, {Nathan I.} and Ginde, {Adit A.} and Prekker, {Matthew E.} and Brown, {Samuel M.} and Peltan, {Ithan D.} and Gong, {Michelle N.} and Aboodi, {Michael S.} and Akram Khan and Exline, {Matthew C.} and Files, {D. Clark} and Gibbs, {Kevin W.} and Lindsell, {Christopher J.} and Rice, {Todd W.} and Jones, {Ian D.} and Natasha Halasa and Talbot, {H. Keipp} and Grijalva, {Carlos G.} and Casey, {Jonathan D.} and Hager, {David N.} and Nida Qadir and Henning, {Daniel J.} and Coughlin, {Melissa M.} and Jarad Schiffer and Vera Semenova and Han Li and Thornburg, {Natalie J.} and Patel, {Manish M.}",

note = "Funding Information: All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. Christopher J. Lindsell reports grants from National Institutes of Health, the Department of Defense, and the Marcus Foundation, and contract support from Endpoint Health, Entegrion, bioMerieux, and Bioscape Digital, outside the submitted work. Daniel J. Henning reports personal fees from CytoVale and grants from Baxter, outside the submitted work. Akram Khan reports grants from United Therapeutics, Actelion Pharmaceuticals, Regeneron, and Reata Pharmaceuticals, outside the submitted work. Samuel M. Brown reports grants from National Institutes of Health, Department of Defense, Intermountain Research and Medical Foundation, and Janssen; consulting fees paid to his employer from Faron and Sedana, all outside the submitted work. Ithan D. Peltan reports grants from the National Institutes of Health and, outside the submitted work, grants from Asahi Kasei Pharma, Immunexpress Inc., Janssen Pharmaceuticals, and Regeneron. Carlos G. Grijalva reports personal fees from Pfizer, Merck, and Sanofi-Pasteur, grants from Campbell Alliance, the National Institutes of Health, the Food and Drug Administration, and the Agency for Health Care Research and Quality, outside the submitted work. Todd W. Rice reports consulting work for Cumberland Pharmaceuticals, Inc., Cytovale, Inc., and Avisa, LLC, outside the submitted work. H. Keipp Talbot has served on a data safety and monitoring board for Seqirus. No other potential conflicts of interest were disclosed.",

year = "2020",

month = sep,

day = "4",

doi = "10.15585/mmwr.mm6935e2",

language = "English (US)",

volume = "69",

pages = "1221--1226",

journal = "Morbidity and Mortality Weekly Report",

issn = "0149-2195",

publisher = "Department of Health and Human Services",

number = "35",

}

TY - JOUR

T1 - Seroprevalence of SARS-CoV-2 among frontline health care personnel in a multistate hospital network - 13 Academic Medical Centers, April-June 2020

AU - Self, Wesley H.

AU - Tenforde, Mark W.

AU - Stubblefield, William B.

AU - Feldstein, Leora R.

AU - Steingrub, Jay S.

AU - Shapiro, Nathan I.

AU - Ginde, Adit A.

AU - Prekker, Matthew E.

AU - Brown, Samuel M.

AU - Peltan, Ithan D.

AU - Gong, Michelle N.

AU - Aboodi, Michael S.

AU - Khan, Akram

AU - Exline, Matthew C.

AU - Files, D. Clark

AU - Gibbs, Kevin W.

AU - Lindsell, Christopher J.

AU - Rice, Todd W.

AU - Jones, Ian D.

AU - Halasa, Natasha

AU - Talbot, H. Keipp

AU - Grijalva, Carlos G.

AU - Casey, Jonathan D.

AU - Hager, David N.

AU - Qadir, Nida

AU - Henning, Daniel J.

AU - Coughlin, Melissa M.

AU - Schiffer, Jarad

AU - Semenova, Vera

AU - Li, Han

AU - Thornburg, Natalie J.

AU - Patel, Manish M.

N1 - Funding Information: All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. Christopher J. Lindsell reports grants from National Institutes of Health, the Department of Defense, and the Marcus Foundation, and contract support from Endpoint Health, Entegrion, bioMerieux, and Bioscape Digital, outside the submitted work. Daniel J. Henning reports personal fees from CytoVale and grants from Baxter, outside the submitted work. Akram Khan reports grants from United Therapeutics, Actelion Pharmaceuticals, Regeneron, and Reata Pharmaceuticals, outside the submitted work. Samuel M. Brown reports grants from National Institutes of Health, Department of Defense, Intermountain Research and Medical Foundation, and Janssen; consulting fees paid to his employer from Faron and Sedana, all outside the submitted work. Ithan D. Peltan reports grants from the National Institutes of Health and, outside the submitted work, grants from Asahi Kasei Pharma, Immunexpress Inc., Janssen Pharmaceuticals, and Regeneron. Carlos G. Grijalva reports personal fees from Pfizer, Merck, and Sanofi-Pasteur, grants from Campbell Alliance, the National Institutes of Health, the Food and Drug Administration, and the Agency for Health Care Research and Quality, outside the submitted work. Todd W. Rice reports consulting work for Cumberland Pharmaceuticals, Inc., Cytovale, Inc., and Avisa, LLC, outside the submitted work. H. Keipp Talbot has served on a data safety and monitoring board for Seqirus. No other potential conflicts of interest were disclosed.

PY - 2020/9/4

Y1 - 2020/9/4

UR - http://www.scopus.com/inward/record.url?scp=85090491736&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85090491736&partnerID=8YFLogxK

U2 - 10.15585/mmwr.mm6935e2

DO - 10.15585/mmwr.mm6935e2

M3 - Article

C2 - 32881855

AN - SCOPUS:85090491736

SN - 0149-2195

VL - 69

SP - 1221

EP - 1226

JO - Morbidity and Mortality Weekly Report

JF - Morbidity and Mortality Weekly Report

IS - 35

ER -

Seroprevalence of SARS-CoV-2 among frontline health care personnel in a multistate hospital network - 13 Academic Medical Centers, April-June 2020

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this